metricas
covid
Buscar en
Clinics
Toda la web
Inicio Clinics Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid a...
Información de la revista
Vol. 68. Núm. 7.
Páginas 1072 (julio 2013)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 68. Núm. 7.
Páginas 1072 (julio 2013)
READERS OPINION
Open Access
Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis
Visitas
507
Azar BaradaranI, Hamid NasriII,
Autor para correspondencia
hamidnasri@med.mui.ac.ir

Tel.: +98 311 669 2609
I Isfahan University of Medical Sciences, Nour Hospital, Department of Pathology, Isfahan/Iran
II Isfahan University of Medical Sciences, Nour Hospital, Department of Nephrology, Division of Nephropathology, Isfahan/Iran
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo

Dear Editor,

We read with great interest the article by Bueno Filho et al. entitled “Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis” that was published in the esteemed journal Clinics. The authors presented an interesting case of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis in a 45-year-old woman (1). I would like to mention a few points regarding this paper. A definitive pathologic IgA nephropathy diagnosis based on immunostaining assays requires the presence of dominant mesangial IgA depositions in the absence of significant C1q depositions to rule out lupus nephritis (25), which the authors should note. Moreover, the detection of significant fibrin deposition along with IgA deposits can help differentiate between primary IgA nephropathy and Henoch-Schönlein purpura nephropathy (25). Therefore, the authors should also discuss this point. Bueno Filho et al. classified the morphologic lesions of IgA nephropathy in renal biopsies as “focal and segmental sclerosis with mild focal and chronic tubulointerstitial damage”. Indeed, as a result of the publication of the Oxford classification of IgA nephropathy in 2009 (2,5), it is necessary to describe the morphologic lesions of IgA nephropathy according to this classification system (68). Furthermore, figure 2C shows a normal glomerulus, which is in contrast to the described morphologic features. The authors reported the final diagnosis as a combination of tuberculous lymphadenitis, cutaneous leukocytoclastic vasculitis, primary IgA nephropathy and anti-phospholipid antibody syndrome. However, the presence of morphologic lesions upon renal biopsy suggests anti-phospholipid syndrome nephropathy and should have been reported (911).

Anti-phospholipid antibody syndrome is a vaso-occlusive disease (12,13) that affects renal tissue and has various morphologic lesions, some of which are characteristic of the disease (14). Accurate documentation and reporting of such rare cases are necessary to determine the complete spectrum of this disorder and improve the understanding of its pathophysiology. Bueno Filho et al. merit compliments for bringing this interesting case to this journal for discussion. Such discussions may help increase awareness of anti-phospholipid antibody syndrome among pathologists and nephrologists, particularly in developing countries.

REFERENCES
[1]
R Bueno Filho , AP Cordeiro , FT de Almeida , C Shaletich , RS Costa , AM Roselino .
Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis.
Clinics, 67 (2012), pp. 1497-1500
[2]
ISD Roberts , HT Cook , S Troyanov , CE Alpers , A Amore , J Barratt , et al.
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.
Kidney Int, 76 (2009), pp. 546-556
[3]
H Nasri .
Comment on: Clinical, Histopathological and Immunofluorescent Findings of IgA Nephropathy and author's reply.
Iran J Immunol, 9 (2012), pp. 266-267
[4]
H Nasri , M Mortazavi , A Ghorbani , H Shahbazian , S Kheiri , A Baradaran , et al.
Oxford-MEST classification in IgA nephropathy patients: A report from Iran.
J Nephropathology, 1 (2012), pp. 31-42
[5]
DC Cattran , R Coppo , HT Cook , J Feehally , ISD Roberts , S Troyanov , et al.
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.
Kidney Int, 76 (2009), pp. 534-545
[6]
H Nasri , S Sajjadieh , S Mardani , A momeni , A Merikhi , Y Madihi , et al.
Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy.
J Nephropathology, 2 (2013), pp. 190-195
[7]
M Mubarak .
Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: The need for more validation studies.
J Nephropathology, 2 (2013), pp. 210-213
[8]
M Mubarak .
Oxford classification of IgA nephropathy: Broadening the scope of the classification.
J Nephropathology, 1 (2012), pp. 13-16
[9]
F Serrano .
Antiphospholipid Syndrome: A complex disease.
J Nephropathology, 2 (2013), pp. 73-74
[10]
A Kronbichler , G Mayer .
Renal involvement in autoimmune connective tissue diseases.
[11]
H Nasri .
Hypertension and renal failure with right arm pulse weakness in a 65 years old man.
J Nephropathology, 1 (2012), pp. 130-133
[12]
S Mardani , H Nasri .
Catastrophic antiphospholipid syndrome presenting with sudden renal failure and past history of long-lasting psychosis and hypertension in a woman.
J Nephropathology, 2 (2013), pp. 110-113
[13]
M Mubarak .
Catastrophic antiphospholipid syndrome presenting with sudden renal failure: The lesson lies in vascular lesions.
J Nephropathology, 2 (2013), pp. 135-138
[14]
RA Sinico , I Cavazzana , M Nuzzo , M Vianelli , P Napodano , P Scaini , et al.
Renal involvement in primary antiphospholipid syndrome: retrospective analysis of 160 patients.
Clin J Am Soc Nephrol, 5 (2010), pp. 1211-1217

No potential conflict of interest was reported.

Copyright © 2013. CLINICS
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos